Stryker Issues Statement Regarding FDA Warning Letter
KALAMAZOO, Mich., Jan. 22 /PRNewswire-FirstCall/ — Stryker Corporation (NYSE:
SYK) today issued the following statement in response to recent media attention
regarding a Warning Letter dated November 28, 2007, that the United States Food
and Drug Administration (FDA) published on its web site on January 15, 2008.
While Stryker does not normally comment on discussions with the FDA, the Company
believes it is obligated to provide additional information to healthcare
professionals, providers and patients in light of several media reports that
draw erroneous conclusions surrounding the Warning Letter.
Most importantly, the Company does not believe there is any clinical evidence to
indicate that the products mentioned in the Warning Letter present a safety
issue to patients. Numerous published independent reports validate the long-term
clinical performance of these products.
The Company takes these matters very seriously and has been cooperating fully